Established in 1982, Randox is dedicated to improving health worldwide by developing pioneering diagnostic technology.
Our Randox Health tests are available to purchase from www.randoxhealth.com As the largest healthcare diagnostics company from the UK and Ireland, Randox undertakes research, development, manufacture and distribution of innovative laboratory tests and equipment. In 2019 Randox, manufactured over 4 billion tests, and operated in 145 countries. With over 2,000 staff, including over 450 research scientists and engineers, key facilities are located in Co Antrim and Co Donegal. Randox focuses on the provision of comprehensive, accurate and timely testing in order to identify risk to health, improve clinical diagnoses and promote preventative healthcare; aiming to achieve better healthcare outcomes whilst reducing the burden on clinical services. In that regard Randox’s innovative Biochip Technology allows many tests to be run simultaneously, greatly improving the diagnostic power available to clinicians. These technologies enable Randox Health Clinics to provide public access to advanced health screening involving of hundreds of diagnostic tests. Such packages provide an extraordinary insight into a person’s current and future health. In early 2020 Randox recognised the threat from COVID-19 and, based on almost 40 years of diagnostic experience, quickly developed a test to accurately identify the virus. Testing at scale commenced within weeks to support both the UK’s National Testing Programme and testing for international travel. Through the enormous effort and commitment of their staff Randox has equipped over 80,000 sq ft of PCR testing facilities in Northern Ireland, Manchester and Greater London, as well as 50,000 sq ft of supporting logistics and engineering space. Randox has amongst the very largest laboratories in Europe, is the leading testing provider in the UK, and was the first to have reported over 100,000 PCR results in a single day. Randox is clear that better diagnostics are unquestionably critical to future improvements within healthcare, and is committed to remaining at the forefront of that field.
16/09/2025
Join Randox Biosciences at the 2025 European Association for the Study of Diabetes, in Vienna, where we are showcasing our groundbreaking diagnostic solutions for Type 1 Diabetes Risk.
Meet with Helena Murray & Kenneth Martin on stand D4.10 to learn more.
11/09/2025
What a view from our latest installation of Vivalytics at Guy’s & St Thomas’ NHS Foundation Trust in London! 👏
Join us on 𝐬𝐭𝐚𝐧𝐝 #𝟐𝟏𝟖 at IBMS for the latest addition to our showcase:
We will be joined by Désirée Prossomariti, Biomedical Research Scientist at Guy’s & St Thomas’ NHS Foundation Trust, to discuss the challenges in diagnosis of Candida auris and the critical role PCR testing plays in the prevention and control of outbreaks.
🤝 𝐖𝐡𝐲 𝐧𝐨𝐭 𝐩𝐥𝐚𝐧 𝐚𝐡𝐞𝐚𝐝? Schedule your meeting with one of our experts today at marketing@randox.com.
Be the first to know and let us send you an email when Randox posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
That’s why for over 35 years Randox has been driving innovations in the crucial field of diagnostics, with the ambition of improving health worldwide.
Randox has a wide-range of divisions such as Quality Control, Reagents, Randox Toxicology, Randox Food Testing and Randox Clinical Laboratory Services (RCLS). This has positioned Randox as a global leader in the healthcare diagnostics industry: every year more than 5% of the world’s population receive a medical diagnosis using Randox products.
The company has over 1400 employees of 44 nationalities, including 400 scientists and engineers. These teams are engaged in pioneering research, developing innovative diagnostic tests and equipment to save and improve lives.
R&D is core to Randox’s philosophy, with up to 16% of turnover committed to R&D each year. Currently over 35 international collaborative projects are underway – and key collaborative partners include the Dana Ferber Cancer Institute, Transgene, and universities including Queen’s University Belfast and Ulster University.
Over 95% of its products are exported worldwide. They are used in hospitals, clinical and molecular laboratories, food testing, forensic toxicology, life sciences and veterinary laboratories. Randox has offices and distribution networks in over 145 countries and there are four key R&D and manufacturing sites in Co. Antrim, Northern Ireland; Donegal, Ireland; Bangalore, India; with a centre under development just outside Washington DC.
Randox’s plant in Dungloe has the potential to revolutionise the economy of West Donegal. Currently employing around 120 staff, this facility will expand to 540 by 2020, to include 180 research scientists and engineers. Randox Dungloe will expand as a world-leading diagnostic R&D, engineering and manufacturing site – providing exciting, highly-skilled employment opportunities within the region.
The company is also expanding its public-facing division – Randox Health. There are now clinics across the UK with new ones due to open in LA and Dubai. There is also a unique mobile service throughout the UK and Ireland. Using highly accurate and sensitive blood tests, Randox scientists assess whole body health with the aim of achieving early diagnosis and promoting an advanced, preventative approach to healthcare. Clients are then empowered to take action to prevent illness from developing and stay healthy for longer.
Randox has also become the first healthcare company to sponsor horse-racing, as a vehicle to promote the message of preventive health to a worldwide audience. It is the title sponsor of the world’s most popular jump race – the Randox Health Grand National – which commands an audience of more than 600 million people.
